more positive results, page-6

Looking more and more like Nymagee may be the first cab off the rank with Hera to follow once they are up and running with cashflow. Should significantly derisk the operation and reduce upfront capex for development. Looking better and better as time goes by.
Surprised by sp weakness but should see a turnaround shortly I expect (or hope).
Hera samples look to be definitely getting pushed aside to fast track the Nymagee results. Must be a big backlog by now.